PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide derived from alpha melanocyte stimulating hormone (alpha MSH). It is widely used as a non selective melanocortin receptor tool compound, with documented binding activity across the MC1R, MC3R, MC4R and MC5R subtypes. This listing is used in laboratory investigations into mitochondrial health and cellular repair, with research focus on melanocortin receptor activation and its secondary, downstream impacts on systemic tissue recovery markers. BPeptide’s PT-141 10mg is supplied as a lyophilized powder and is verified for identity and purity by independent third party analysis.
Cellular Repair Tracking
Studied for downstream signaling effects relevant to tissue recovery and cellular repair markers following melanocortin receptor activation.
Mitochondrial Health Research
Used in protocols tracking mitochondrial efficiency and tissue integrity markers across extended observation cycles.
Melanocortin Receptor Activation
Non selective agonist activity across MC1R, MC3R, MC4R and MC5R, well characterized in published receptor pharmacology literature.
Stable Cyclic Structure
The cyclic lactam architecture improves resistance to enzymatic degradation, supporting reproducible in vitro assay conditions.




Reviews
There are no reviews yet.